Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.
D. Boulware, Mucunguzi Atukunda, E. Kagimu, et al.. (2023). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. Cited 42 times. https://doi.org/10.1093/cid/ciad440
Performance of the Cryptococcal Antigen Lateral Flow Assay in Non-HIV-Related Cryptococcosis
A. Jitmuang, Anil A. Panackal, P. Williamson, et al.. (2015). Journal of Clinical Microbiology. Cited 42 times. https://doi.org/10.1128/JCM.02223-15
Chemokine receptor CXCR3 is required for lethal brain pathology but not pathogen clearance during cryptococcal meningoencephalitis
Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of post-infectious inflammatory response syndrome
Cryptococcal Meningitis and Post-Infectious Inflammatory Response Syndrome in a Patient With X-Linked Hyper IgM Syndrome: A Case Report and Review of the Literature
Tocilizumab as a Potential Adjunctive Therapy to Corticosteroids in Cryptococcal Post-infectious Inflammatory Response Syndrome (PIIRS): a Report of Two Cases